HomeCompareMDXHF vs GBDC

MDXHF vs GBDC: Dividend Comparison 2026

MDXHF yields 4545.45% · GBDC yields 11.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MDXHF wins by $24684467220167.39M in total portfolio value
10 years
MDXHF
MDXHF
● Live price
4545.45%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24684467220188.17M
Annual income
$23,660,503,792,881,107,000.00
Full MDXHF calculator →
GBDC
GBDC
● Live price
11.85%
Share price
$12.66
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.78M
Annual income
$16,389,263.41
Full GBDC calculator →

Portfolio growth — MDXHF vs GBDC

📍 MDXHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMDXHFGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MDXHF + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MDXHF pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MDXHF
Annual income on $10K today (after 15% tax)
$386,363.64/yr
After 10yr DRIP, annual income (after tax)
$20,111,428,223,948,940,000.00/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.11/yr
After 10yr DRIP, annual income (after tax)
$13,930,873.90/yr
At 15% tax rate, MDXHF beats the other by $20,111,428,223,935,010,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MDXHF + GBDC for your $10,000?

MDXHF: 50%GBDC: 50%
100% GBDC50/50100% MDXHF
Portfolio after 10yr
$12342233610104.47M
Annual income
$11,830,251,896,448,748,000.00/yr
Blended yield
95.85%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

MDXHF
No analyst data
Altman Z
-81.2
Piotroski
3/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.6% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MDXHF buys
0
GBDC buys
0
No recent congressional trades found for MDXHF or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMDXHFGBDC
Forward yield4545.45%11.85%
Annual dividend / share$2.00$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.1%
Portfolio after 10y$24684467220188.17M$20.78M
Annual income after 10y$23,660,503,792,881,107,000.00$16,389,263.41
Total dividends collected$24614959662391.29M$20.36M
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: MDXHF vs GBDC ($10,000, DRIP)

YearMDXHF PortfolioMDXHF Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$465,245$454,545.45$12,490$1,790.28+$452.8KMDXHF
2$20,261,851$19,764,038.00$16,522$3,157.73+$20.25MMDXHF
3$826,111,319$804,431,138.78$23,578$5,898.68+$826.09MMDXHF
4$31,536,344,373$30,652,405,261.22$37,115$11,886.75+$31536.31MMDXHF
5$1,127,331,439,718$1,093,587,551,239.73$66,136$26,423.57+$1127331.37MMDXHF
6$37,741,323,559,434$36,535,078,918,935.74$137,257$66,491.44+$37741323.42MMDXHF
7$1,183,503,101,225,504$1,143,119,885,016,909.50$341,734$194,868.54+$1183503100.88MMDXHF
8$34,767,541,536,847,464$33,501,193,218,536,172.00$1,050,788$685,133.02+$34767541535.80MMDXHF
9$956,975,165,707,534,300$919,773,896,263,107,700.00$4,099,314$2,974,971.01+$956975165703.44MMDXHF
10$24,684,467,220,188,170,000$23,660,503,792,881,107,000.00$20,775,530$16,389,263.41+$24684467220167.39MMDXHF

MDXHF vs GBDC: Complete Analysis 2026

MDXHFStock

MedX Health Corp, a medical device and software company, develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market; and SIAMETRICS, SIMSYS, and MoleMate, which creates real-time images for physicians and dermatologists to evaluate various types of moles or lesions within seconds. It operates DermSecure telemedicine platform that enables the web-based operation of its SIAscopy scanning technology and allows the company to deploy its technology in networks of third-party locations from which patients' mole and lesion images along with other relevant patient information can be connected to specialist physicians for remote assessment. The company was incorporated in 1999 and is headquartered in Mississauga, Canada.

Full MDXHF Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this MDXHF vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MDXHF vs SCHDMDXHF vs JEPIMDXHF vs OMDXHF vs KOMDXHF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.